相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global Frequencies of Clinically ImportantHLAAlleles and Their Implications For the Cost-Effectiveness of Preemptive Pharmacogenetic Testing
Yitian Zhou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?
Beatriz Carvalho Henriques et al.
FRONTIERS IN GENETICS (2020)
Cross-ethnicity tagging SNPs for HLA alleles associated with adverse drug reaction
Michael Erlichster et al.
PHARMACOGENOMICS JOURNAL (2019)
A Screening Test for HLA-B*15:02 in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse Events
Hua Fang et al.
FRONTIERS IN PHARMACOLOGY (2019)
HLA-associated antiepileptic drug-induced cutaneous adverse reactions
Kerry A. Mullan et al.
HLA (2019)
The MHC in the era of next-generation sequencing: Implications for bridging structure with function
Effie W. Petersdorf et al.
HUMAN IMMUNOLOGY (2019)
SNP-based HLA allele tagging, imputation and association with antiepileptic drug-induced cutaneous reactions in Hong Kong Han Chinese
H. Gui et al.
PHARMACOGENOMICS JOURNAL (2018)
The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions
Patricia T. Illing et al.
IMMUNOGENETICS (2017)
Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
M. Verbelen et al.
PHARMACOGENOMICS JOURNAL (2017)
HLA Association with Drug-Induced Adverse Reactions
Wen-Lang Fan et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation
Marek Wieczorek et al.
FRONTIERS IN IMMUNOLOGY (2017)
Deep sequencing of the MHC region in the Chinese population contributes to studies of complex disease
Fusheng Zhou et al.
NATURE GENETICS (2016)
Genotypes at rs2844682 and rs3909184 have no clinical value in identifying HLA-B*15:02 carriers
Guang-dan Zhu et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
A global reference for human genetic variation
David M. Altshuler et al.
NATURE (2015)
Accuracy of SNPs to predict risk of HLA alleles associated with drug-induced hypersensitivity events across racial groups
Yijing He et al.
PHARMACOGENOMICS (2015)
Development of a simple genotyping method for the HLA-A*31:01-tagging SNP in Japanese
Keiko Maekawa et al.
PHARMACOGENOMICS (2015)
Tag SNPs for HLA-B alleles that are associated with drug response and disease risk in the Chinese Han population
X. Liu et al.
PHARMACOGENOMICS JOURNAL (2015)
Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions
Ursula Amstutz et al.
EPILEPSIA (2014)
Ancestry-based pharmacogenomics, adverse reactions and carbamazepine: is the FDA warning correct?
P. W. Payne
PHARMACOGENOMICS JOURNAL (2014)
Carbamazepine-induced cutaneous reactions: A simple assay to identify patients carrying the HLA-A*31:01 allele
Ketil Thorstensen et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2014)
Major Histocompatibility Complex Genomics and Human Disease
John Trowsdale et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 14 (2013)
HLA-A*31:01 and HLA-B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children
U. Amstutz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
New pharmacogenetic test for detecting an HLA-A*31:01 allele using the InvaderPlus assay
Masayuki Aoki et al.
PHARMACOGENETICS AND GENOMICS (2012)
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
Mark McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The HLA system: Genetics, immunology, clinical testing, and clinical implications
Sung Yoon Choo
YONSEI MEDICAL JOURNAL (2007)
A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC
Paul I. W. de Bakker et al.
NATURE GENETICS (2006)
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients
M Pirmohamed et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
The Canadian Adverse Events Study:: the incidence of adverse events among hospital patients in Canada
GR Baker et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2004)
分享论文
